# Sildenafil for Swimming-Induced Pulmonary Edema (SIPE) Prevention

> **NCT03686813** · PHASE2 · COMPLETED · sponsor: **Duke University** · enrollment: 18 (actual)

## Conditions studied

- Edema, Pulmonary
- Immersion
- Diving

## Interventions

- **DRUG:** Sildenafil Citrate
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03686813
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-15
- **Primary completion:** 2021-10-29
- **Final completion:** 2021-10-29
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03686813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03686813, "Sildenafil for Swimming-Induced Pulmonary Edema (SIPE) Prevention". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03686813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*